| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maravai Lifesciences Holdings, Inc. (MRVI) has 15 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. MRVI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 750.0K | $3.36M | - | |
| Other | 727.2K | $3.26M | - | |
| CFO | 674.6K | $3.03M | - | |
| Other | 477.9K | $2.14M | - | |
| CEO | 466.8K | $2.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2020 | Gray Susannah | Director | Buy | 20,000 | $27.00 | $540,000.00 | +168.7% | |
| Nov 24, 2020 | Hance Robert B | Director | Buy | 10,000 | $27.00 | $270,000.00 | +84.4% | |
| Nov 24, 2020 | Prahalad Murali | Director | Buy | 18,000 | $27.00 | $486,000.00 | +151.9% | |
| Nov 24, 2020 | Lucier Gregory T45 | Director | Buy | 15,000 | $27.00 | $405,000.00 | +126.6% | |
| Nov 24, 2020 | Hopfield Jessica | Director | Buy | 50,000 | $27.00 | $1,350,000.00 | +421.9% |